Tandem Capital Management Corp Boston Scientific Corp Transaction History

Tandem Capital Management Corp

$176 Million
Q2 2025

A detailed history of Tandem Capital Management Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Tandem Capital Management Corp holds 53,044 shares of BSX stock, worth $5.47 Million. This represents 3.24% of its overall portfolio holdings.

Number of Shares

53,044

Previous 53,704 1.23%

Holding current value

$5.47 Million

Previous $5.42 Million 5.17%

% of portfolio

3.24%

Previous 3.34%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$89.7 - $107.41 $59,202 - $70,890	-660 Reduced 1.23%	53,044 $5.7 Million
Q1 2025 Apr 22, 2025	SELL	$89.38 - $106.18 $75,257 - $89,403	-842 Reduced 1.54%	53,704 $5.42 Million
Q4 2024 Jan 24, 2025	SELL	$83.62 - $91.5 $50,590 - $55,357	-605 Reduced 1.1%	54,546 $4.87 Million
Q3 2024 Oct 25, 2024	SELL	$72.96 - $84.0 $233,471 - $268,800	-3,200 Reduced 5.48%	55,151 $4.62 Million
Q3 2024 Oct 23, 2024	BUY	$72.96 - $84.0 $35,385 - $40,740	485 Added 0.84%	58,351 $4.89 Million
Q2 2024 Jul 08, 2024	SELL	$67.33 - $77.71 $32,655 - $37,689	-485 Reduced 0.83%	57,866 $4.46 Million
Q1 2024 May 16, 2024	SELL	$57.6 - $68.62 $7,200 - $8,577	-125 Reduced 0.21%	58,351 $4 Million
Q4 2023 Feb 02, 2024	SELL	$48.64 - $57.81 $68,096 - $80,934	-1,400 Reduced 2.34%	58,476 $3.38 Million
Q3 2023 Oct 30, 2023	SELL	$50.19 - $54.68 $22,585 - $24,606	-450 Reduced 0.75%	59,876 $3.16 Million
Q2 2023 Aug 15, 2023	SELL	$49.72 - $54.64 $29,832 - $32,784	-600 Reduced 0.98%	60,326 $3.26 Million
Q1 2023 May 04, 2023	SELL	$45.09 - $50.03 $21,553 - $23,914	-478 Reduced 0.78%	60,926 $3.05 Million
Q4 2022 Jan 18, 2023	SELL	$39.56 - $47.22 $30,065 - $35,887	-760 Reduced 1.22%	61,404 $0
Q3 2022 Oct 24, 2022	SELL	$36.71 - $109.66 $3,303 - $9,869	-90 Reduced 0.14%	62,164 $2.52 Million
Q1 2022 Apr 26, 2022	SELL	$40.9 - $45.1 $21,268 - $23,452	-520 Reduced 0.83%	62,254 $2.73 Million
Q4 2021 Feb 04, 2022	BUY	$38.07 - $44.87 $42,828 - $50,478	1,125 Added 1.82%	62,774 $2.67 Million
Q3 2021 Oct 28, 2021	BUY	$41.23 - $45.88 $11,544 - $12,846	280 Added 0.46%	61,649 $2.68 Million
Q2 2021 Aug 06, 2021	SELL	$38.58 - $44.24 $10,416 - $11,944	-270 Reduced 0.44%	61,369 $2.62 Million
Q1 2021 May 12, 2021	SELL	$35.27 - $39.67 $19,398 - $21,818	-550 Reduced 0.88%	61,639 $2.38 Million
Q4 2020 Feb 01, 2021	BUY	$33.15 - $41.97 $21,547 - $27,280	650 Added 1.06%	62,189 $2.24 Million
Q3 2020 Nov 03, 2020	SELL	$34.44 - $42.23 $10,332 - $12,668	-300 Reduced 0.49%	61,539 $2.35 Million
Q2 2020 Aug 13, 2020	SELL	$30.19 - $39.11 $188,989 - $244,828	-6,260 Reduced 9.19%	61,839 $2.17 Million
Q1 2020 May 12, 2020	BUY	$25.83 - $45.71 $52,176 - $92,334	2,020 Added 3.06%	68,099 $2.22 Million
Q4 2019 Mar 04, 2020	BUY	$37.87 - $45.37 $2.5 Million - $3 Million	66,079 New	66,079 $2.99 Million

Others Institutions Holding BSX

# of Institutions

1,875

Shares Held

1.22B

Call Options Held

9.86M

Put Options Held

7.26M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $148B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tandem Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Tandem Capital Management Corp with notifications on news.

Account

Tandem Capital Management Corp Boston Scientific Corp Transaction History